http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02202898-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 1989-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_832abf17ef2dad99fe33d245bad5371f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df93ffd243c9148aca477b8d219cbdaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6905eaa630b0124de8a57cdd7249dd94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8674ea2eb81382e4d43803ab0e316f
publicationDate 1990-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02202898-A
titleOfInvention Enzyme-inhibiting urea derivative of dipeptide
abstract NEW MATERIAL: A compd. (salt) represented by formula I [wherein R 1 is H, a (substd.) alkyl or (substd.) aryl, R 2 and R 3 are H, an alkyl or aryl, R 4 is OH or NH 2 , R 5 is the same as R 1 and forms a cyclic group along with R 1 , A and B are each a (non-)natural amino acid, X can be absent, or represents O, S or CO, and p and q are 0 or 1-4]. n EXAMPLE: 1-Cyclohexyl-6-(2-pyridyl)-2S-[N-[N-(piperadin-1-yl-carbonyl)-L- phenylalanyl-L-norvaryl]amino]-3S-hexanol. n USE: A therapeutic agent for hypertension and heart failure. n PROCESS: For example, a compd. represented by formula II is reacted with a carbonic acid deriv. represented by formula III (R 9 and R 10 are halogen or alkoxy) and the reaction product is reacted with amines represented by formula IV to obtain the compd. represented by the formula I. n COPYRIGHT: (C)1990,JPO
priorityDate 1988-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 31.